Aton Ra Partners Burning Rock Biotech LTD Transaction History

Aton Ra Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.75 - $10.44 $64,226 - $383,158	-36,701 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.7 - $10.23 $41,097 - $62,750	-6,134 Reduced 14.32%	36,701 $341,000
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $20,123 - $36,576	2,134 Added 5.24%	42,835 $408,000
Q3 2021 Nov 15, 2021	BUY	$17.37 - $27.92 $91,331 - $146,803	5,258 Added 14.84%	40,701 $728,000
Q2 2021 Aug 12, 2021	SELL	$26.14 - $37.45 $5,410 - $7,752	-207 Reduced 0.58%	35,443 $1.04 Million
Q1 2021 May 17, 2021	BUY	$23.5 - $39.58 $837,775 - $1.41 Million	35,650 New	35,650 $960,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.